These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17378442)

  • 21. A unique metabolite of nimesulide.
    Sarkar P; McIntosh JM; Leavitt R; Gouthro H
    J Anal Toxicol; 1997; 21(3):197-202. PubMed ID: 9171202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bioavailability and pharmacokinetics of DRF-4367, a new COX-2 inhibitor in rats.
    Ramesh M; Mamidi RN; Jagannath K; Singh SK; Rao KS; Rao YK; Seshagirirao C; Rajagopalan R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2003; 28(2):137-41. PubMed ID: 12877572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration.
    Carretero M; Rodríguez C; San Andrés MI; Forés P; de Lucas JJ; Nieto J; Waxman S; San Andrés MD; González F
    Equine Vet J; 2002 Jul; 34(4):360-5. PubMed ID: 12117107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lithium poisoning and the use of nimesulide].
    Bocchia M; Bertola G; Morganti D; Toscano M; Colombo E
    Recenti Prog Med; 2001; 92(7-8):462. PubMed ID: 11475788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analgesic activity of nimesulide and diclofenac by intramuscular route: correlation with pharmacokinetic profile of nimesulide.
    Gupta SK; Velpandian T; Mathur P; Sengupta S
    Pharmacology; 1998 Mar; 56(3):137-43. PubMed ID: 9532613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on the use of cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs in horses.
    Ziegler A; Fogle C; Blikslager A
    J Am Vet Med Assoc; 2017 Jun; 250(11):1271-1274. PubMed ID: 28509650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral administration of tepoxalin in the horse: a PK/PD study.
    Giorgi M; Cuniberti B; Ye G; Barbero R; Sgorbini M; Vercelli C; Corazza M; Re G
    Vet J; 2011 Oct; 190(1):143-9. PubMed ID: 21036634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nimesulide: a lower risk treatment in rheumatic diseases].
    Trnavský K
    Vnitr Lek; 2004 Feb; 50(2):157-62. PubMed ID: 15077593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diffusion of nimesulide gel into synovial fluid: a comparison between administration routes.
    Erdogan F; Ergün H; Gökay NS; Gulmez SE; Bolay B; Tulunay FC
    Int J Clin Pharmacol Ther; 2006 Jun; 44(6):270-5. PubMed ID: 16800099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
    Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
    Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of marbofloxacin in horses.
    Bousquet-Melou A; Bernard S; Schneider M; Toutain PL
    Equine Vet J; 2002 Jul; 34(4):366-72. PubMed ID: 12117108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.
    Davies NM; McLachlan AJ; Day RO; Williams KM
    Clin Pharmacokinet; 2000 Mar; 38(3):225-42. PubMed ID: 10749518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetic profile of nimesulide in healthy volunteers.
    Bernareggi A
    Drugs; 1993; 46 Suppl 1():64-72. PubMed ID: 7506196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of age and disease on the pharmacokinetics of nimesulide.
    Olive G; Rey E
    Drugs; 1993; 46 Suppl 1():73-8. PubMed ID: 7506197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of malnutrition on the oral pharmacokinetics of nimesulide in rats.
    Carrasco-Portugal Mdel C; Camacho-Vieyra AG; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2008; 51():52-4. PubMed ID: 19544676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
    Lees P; Landoni MF; Giraudel J; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen.
    Shah AA; Thjodleifsson B; Murray FE; Kay E; Barry M; Sigthorsson G; Gudjonsson H; Oddsson E; Price AB; Fitzgerald DJ; Bjarnason I
    Gut; 2001 Mar; 48(3):339-46. PubMed ID: 11171823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical pharmacology of the selective COX-2 inhibitors].
    Burian M; Geisslinger G
    Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.